Anti-CD123 Targeted Therapy with Talacotuzumab in Advanced MDS and AML after Failing Hypomethylating Agents - Final Results of the Samba TrialAnne Sophie Kubasch, Uwe Platzbecker, Fatiha Chermat et al.|Blood|2018Cited by 17
An Artificial Intelligence-Based Federated Learning Platform to Boost Precision Medicine in Rare Hematological Diseases: An Initiative By GenoMed4all and Synthema ConsortiaGianluca Asti, Federico Álvarez, Saverio D’Amico et al.|Blood|2024Cited by 6
Disease-modifying activity of ruxolitinib in a patient with <i>JAK2</i>-negative CMML-2Silvan Francke, Uwe Platzbecker, Anna Mies et al.|Leukemia & lymphoma/Leukemia and lymphoma|2016Cited by 5